Invesco Ltd. - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 32 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$76,150,000
-30.7%
41,769,000
-8.1%
0.03%
-34.1%
Q3 2014$109,884,000
+20.1%
45,430,000
-2.6%
0.04%
+22.2%
Q2 2014$91,527,000
+16.4%
46,623,000
+0.2%
0.04%
+12.5%
Q1 2014$78,660,000
+15.6%
46,527,000
+1.9%
0.03%
+18.5%
Q4 2013$68,041,000
+22.1%
45,646,000
+0.5%
0.03%
+12.5%
Q3 2013$55,705,000
+2.9%
45,404,000
+0.1%
0.02%
-4.0%
Q2 2013$54,115,00045,356,0000.02%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
GRACE BROTHERS MANAGEMENT LLC 2,800,000$5,117,0004.90%
SILVERBACK ASSET MANAGEMENT LLC 18,209,000$33,322,0004.30%
RAVEN ROCK CAPITAL MANAGEMENT, LLC 1,000,000$1,990,0002.80%
Verition Fund Management LLC 5,504,000$10,062,0002.26%
CAMDEN ASSET MANAGEMENT L P /CA 26,798,000$48,856,0001.81%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,600,000$15,679,0001.60%
TENOR CAPITAL MANAGEMENT Co., L.P. 3,000,000$5,490,0001.46%
BASSO CAPITAL MANAGEMENT, L.P. 4,825,000$8,782,0001.40%
Wellesley Asset Management 12,564$23,006,0001.35%
WOLVERINE ASSET MANAGEMENT LLC 31,156,000$56,979,0001.11%
View complete list of SALIX PHARMACEUTICALS INC shareholders